A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

Clinical trial NCT07613307 · RECRUITING

Trial details

NCT number: NCT07613307
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Diabetes Melletus Glucose Metabolism Disorders Metabolic Disorders Nutritional and Metabolic Diseases Endocrine System Diseases Feeding Behavior Behavior Fasting Glucagon-Like Peptide-1 Receptor Glucagon-Like Peptide Receptors Receptors, G-Protein-Coupled

Start date: 2026-07-15
Primary completion: 2027-05-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.